Envestnet Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $301M | Buy |
613,387
+94,829
| +18% | +$51.5M | 0.08% | 227 |
|
|
2025
Q4 | $300M | Sell |
518,558
-49,913
| -9% | -$28.2M | 0.09% | 207 |
|
|
2025
Q3 | $276M | Sell |
568,471
-57,885
| -9% | -$26.9M | 0.08% | 238 |
|
|
2025
Q2 | $254M | Sell |
626,356
-173,941
| -22% | -$72.7M | 0.07% | 245 |
|
|
2025
Q1 | $398M | Sell |
800,297
-13,929
| -2% | -$7.54M | 0.13% | 146 |
|
|
2024
Q4 | $424M | Sell |
814,226
-95,471
| -10% | -$52.5M | 0.14% | 128 |
|
|
2024
Q3 | $563M | Buy |
909,697
+11,181
| +1% | +$6.62M | 0.18% | 95 |
|
|
2024
Q2 | $497M | Buy |
898,516
+25,862
| +3% | +$14.8M | 0.17% | 106 |
|
|
2024
Q1 | $507M | Buy |
872,654
+160,901
| +23% | +$90.3M | 0.19% | 97 |
|
|
2023
Q4 | $378M | Buy |
711,753
+13,308
| +2% | +$6.44M | 0.16% | 117 |
|
|
2023
Q3 | $354M | Buy |
698,445
+125,267
| +22% | +$66.8M | 0.16% | 116 |
|
|
2023
Q2 | $299M | Buy |
573,178
+1,890
| +0.3% | +$1.02M | 0.13% | 128 |
|
|
2023
Q1 | $329M | Sell |
571,288
-42,418
| -7% | -$23.9M | 0.16% | 105 |
|
|
2022
Q4 | $338M | Buy |
613,706
+22,512
| +4% | +$11.9M | 0.18% | 103 |
|
|
2022
Q3 | $300M | Buy |
591,194
+10,812
| +2% | +$6.05M | 0.17% | 96 |
|
|
2022
Q2 | $315M | Buy |
580,382
+4,215
| +0.7% | +$2.32M | 0.18% | 101 |
|
|
2022
Q1 | $340M | Buy |
576,167
+8,063
| +1% | +$4.63M | 0.17% | 101 |
|
|
2021
Q4 | $379M | Buy |
568,104
+17,592
| +3% | +$11M | 0.19% | 97 |
|
|
2021
Q3 | $315M | Buy |
550,512
+24,356
| +5% | +$13.4M | 0.17% | 105 |
|
|
2021
Q2 | $265M | Buy |
526,156
+3,096
| +0.6% | +$1.46M | 0.15% | 120 |
|
|
2021
Q1 | $239M | Buy |
523,060
+48,397
| +10% | +$23.1M | 0.16% | 117 |
|
|
2020
Q4 | $221M | Sell |
474,663
-5,921
| -1% | -$2.78M | 0.17% | 100 |
|
|
2020
Q3 | $212M | Buy |
480,584
+25,119
| +6% | +$10.4M | 0.19% | 92 |
|
|
2020
Q2 | $165M | Buy |
455,465
+67,048
| +17% | +$22.5M | 0.16% | 102 |
|
|
2020
Q1 | $110M | Buy |
388,417
+62,711
| +19% | +$19.8M | 0.13% | 126 |
|
|
2019
Q4 | $106M | Buy |
325,706
+45,538
| +16% | +$13.8M | 0.11% | 147 |
|
|
2019
Q3 | $81.6M | Buy |
280,168
+22,736
| +9% | +$6.51M | 0.09% | 170 |
|
|
2019
Q2 | $75.6M | Buy |
257,432
+32,130
| +14% | +$8.85M | 0.1% | 156 |
|
|
2019
Q1 | $61.7M | Sell |
225,302
-1,745
| -0.8% | -$434K | 0.08% | 181 |
|
|
2018
Q4 | $50.8M | Buy |
227,047
+224,081
| +7,555% | +$52.6M | 0.08% | 182 |
|
|
2018
Q3 | $724K | Sell |
2,966
-42,330
| -93% | -$9.74M | ﹤0.01% | 830 |
|
|
2018
Q2 | $9.38M | Buy |
45,296
+485
| +1% | +$103K | 0.02% | 339 |
|
|
2018
Q1 | $9.26M | Sell |
44,811
-16,452
| -27% | -$3.45M | 0.03% | 245 |
|
|
2017
Q4 | $11.6M | Buy |
61,263
+2,916
| +5% | +$559K | 0.03% | 359 |
|
|
2017
Q3 | $11M | Sell |
58,347
-3,414
| -6% | -$618K | 0.03% | 347 |
|
|
2017
Q2 | $10.8M | Buy |
61,761
+3,209
| +5% | +$539K | 0.03% | 354 |
|
|
2017
Q1 | $8.99M | Buy |
58,552
+6,243
| +12% | +$954K | 0.03% | 388 |
|
|
2016
Q4 | $7.38M | Buy |
52,309
+1,320
| +3% | +$195K | 0.03% | 422 |
|
|
2016
Q3 | $8.11M | Sell |
50,989
-20,882
| -29% | -$3.22M | 0.03% | 423 |
|
|
2016
Q2 | $10.6M | Buy |
71,871
+3,576
| +5% | +$528K | 0.04% | 357 |
|
|
2016
Q1 | $9.67M | Sell |
68,295
-6,964
| -9% | -$933K | 0.04% | 357 |
|
|
2015
Q4 | $10.7M | Buy |
75,259
+3,138
| +4% | +$419K | 0.05% | 327 |
|
|
2015
Q3 | $8.82M | Sell |
72,121
-2,269
| -3% | -$296K | 0.04% | 354 |
|
|
2015
Q2 | $9.65M | Sell |
74,390
-6,254
| -8% | -$815K | 0.05% | 392 |
|
|
2015
Q1 | $10.8M | Buy |
80,644
+73,584
| +1,042% | +$9.49M | 0.06% | 333 |
|
|
2014
Q4 | $885K | Sell |
7,060
-3,162
| -31% | -$384K | 0.01% | 560 |
|
|
2014
Q3 | $1.24M | Sell |
10,222
-2,624
| -20% | -$319K | 0.01% | 516 |
|
|
2014
Q2 | $1.52M | Sell |
12,846
-54
| -0.4% | -$6.36K | 0.02% | 428 |
|
|
2014
Q1 | $1.55M | Buy |
12,900
+1,197
| +10% | +$142K | 0.02% | 353 |
|
|
2013
Q4 | $1.3M | Sell |
11,703
-8,792
| -43% | -$874K | 0.01% | 381 |
|
|
2013
Q3 | $1.89M | Sell |
20,495
-1,766
| -8% | -$160K | 0.02% | 295 |
|
|
2013
Q2 | $1.88M | Buy |
+22,261
| New | +$1.85M | 0.02% | 286 |
|
Other funds holding TMO
VCM
Envestnet Asset Management's TMO Position: Q1 2026 in Review
Envestnet Asset Management increased its Thermo Fisher Scientific (TMO) stake by 18% in Q1 2026, buying an estimated $51.5M and bringing the position to 613,387 shares worth $301M. The position accounts for 0.08% of the portfolio, ranked #227.
Envestnet Asset Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $563M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Envestnet Asset Management held 613,387 shares of Thermo Fisher Scientific worth $301M as of Q1 2026.
- Envestnet Asset Management bought 94,829 Thermo Fisher Scientific shares in Q1 2026, an estimated $51.5M.
- Thermo Fisher Scientific made up 0.08% of Envestnet Asset Management's portfolio in Q1 2026, its #227 holding.
- Envestnet Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Envestnet Asset Management's Thermo Fisher Scientific position peaked at $563M in Q3 2024.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.